More than 100 COVID-19 patients at a hospital in Beijing are receiving injections of mesenchymal stem cells to help them fend off the disease. The experimental treatment is part of an ongoing clinical trial, which coordinators say has shown early promise in alleviating COVID-19 symptoms.
Several experts express skepticism of the trial’s early results, suggest resources would be better spent exploring other treatments.
Comments are closed.